---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-005797"
form_type: "8-K"
ticker: null
cik: "0000922247"
company_name: "Cyclo Therapeutics, Inc."
filed_at: "2023-03-08T23:59:59+00:00"
generated_at: "2026-06-18T09:11:49.079047+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cyclo Therapeutics stockholders approve increase in authorized common shares to 50M

## Summary
- Stockholders voted to increase authorized common shares from 20M to 50M at Special Meeting on March 3, 2023.
- Proposal passed with 5,712,437 for, 553,794 against, 36,599 abstain; quorum of 63.7% of outstanding shares.
- Certificate of Amendment filed with Nevada Secretary of State on March 7, 2023.
- Company can now issue additional shares, potentially for financing or strategic purposes.

## SEC filing metadata
- accession: 0001437749-23-005797
- form_type: 8-K
- cik: 0000922247
- company_name: Cyclo Therapeutics, Inc.
- filed_at: 2023-03-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/922247/000143774923005797/0001437749-23-005797-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/922247/000143774923005797/ctdh20230308_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-005797
- JSON: https://secwatch.observer/filing/0001437749-23-005797.json
- Plain text: https://secwatch.observer/filing/0001437749-23-005797.txt

## Key facts
- Governance Changes
  Cyclo Therapeutics, Inc.: Increased number of authorized shares of common stock from 20,000,000 to 50,000,000 via Certificate of Amendment to Articles of Incorporation (effective 2023-03-07).
  - Change: charter amendment
  - Effective: 2023-03-07
  source text: On March 3, 2023, Cyclo Therapeutics, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”), at which the Company’s stockholders approved an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of common stock from 20,000,000 to 50,000,000. The Company filed a Certificate of Amendment with the Secretary of State of the State of Nevada on March 7, 2023 to effect such increase.
  evidence_url: https://www.sec.gov/Archives/edgar/data/922247/000143774923005797/0001437749-23-005797-index.htm
- Shareholder Votes
  Cyclo Therapeutics, Inc. shareholders approved Approve amendment to Articles of Incorporation increasing authorized shares to 50,000,000 at the 2023-03-03 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-03-03
  source text: Stockholders holding an aggregate of 6,302,829 shares of common stock, representing 63.7% of the outstanding shares of the Company’s common stock as of the record date for the Special Meeting, and which constituted a quorum, were present in person or represented by proxy at the Special Meeting, at which the proposal was approved. The results of the voting for the proposal at the Special Meeting are presented below. For Against Abstain Broker Non-Votes 5,712,437 553,794 36,599 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/922247/000143774923005797/0001437749-23-005797-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.